Stacy Lindborg serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Stacy Lindborg has executed 8 insider transactions totaling $44.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 6, 2025 involved exercising options for 1,667 shares valued at $0.
Stacy Lindborg currently holds 3,584 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stacy Lindborg has been a net buyer of BCLI stock. They have purchased $44.9K and sold $0 worth of shares.
Stacy Lindborg's most recent insider trade was on Sep 6, 2025, when they sold 1,667 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.98 |
| Discretionary |
| Mar 11, 2024 | BCLI | $0 | Award | 241,935 | $N/A | Discretionary |
| Sep 1, 2023 | BCLI | $20.4K | Purchase | 11,500 | $1.77 | Discretionary |
| Aug 2, 2023 | BCLI | $0 | Award | 35,000 | $N/A | Discretionary |
| Apr 20, 2023 | BCLI | $0 | Award | 75,000 | $N/A | Discretionary |
| Dec 7, 2022 | BCLI | $0 | Award | 35,000 | $N/A | Discretionary |
| Jun 1, 2020 | BCLI | $0 | Award | 25,000 | $N/A | Discretionary |